The European Medicines Agency (EMA) has discovered a possible link between the Johnson & Johnson (J&J) Covid vaccine and another rare blood clotting condition.
The EMA, the European Union’s drug regulator, announced the possible link between venous thromboembolism (VTE) and the J&J vaccination and have recommend it be listed as a potential side effect to the jab.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
RT reports: After a meeting of its Pharmacovigilance Risk Assessment Committee (PRAC), the drug regulator said on Friday that venous thromboembolism, a potentially life-threatening blood clotting condition, should be added to the J&J vaccine’s product label as a rare possible side effect. The illness causes a clot to form in the vein of a leg, arm, or the groin, which can then travel to the lungs and cut off the blood supply.
Putin Delivers Biden an Almighty Slap: 'Don’t Blame Me For Inflation'
Nestle CEO: Humans Do NOT Have a Right to Water, Should Be Privatized and Controlled
World Economic Forum To “Freeze Bank Accounts” of Meat Eaters To "Educate Them”
Biden Announces a New Plandemic Right before the Midterm Elections
Proof of Time Travel? These Famous Faces Appear Throughout History
Putin Declares Victory Over New World Order: 'Humanity Has Woken Up'
Mass Cattle Deaths Are an ‘Inside Job’ Designed To Cause Food Shortages in America
Christina Aguilera Performs For Kids Wearing GIGANTIC Strap-On
Angelina Jolie Admits to ‘Gruesome Illuminati Blood Rituals’
Alongside the blood clotting concern, the EMA warned that immune thrombocytopenia, a disorder that causes the body to mistakenly attack its own blood platelets, should be added to the drug’s potential side effects. It also recommended adding it as a possible adverse reaction to AstraZeneca’s Covid vaccine.
This is not the first time that J&J has been advised to add a blood clotting risk as a potential side effect, with the PRAC previously highlighting the potential link between the company’s vaccine and cerebral venous sinus thrombosis, as well as splanchnic vein thrombosis – clots that target the brain and the abdomen respectively.
The EMA did not announce any change to its previous risk assessment of the J&J vaccine, which stated that the positives outweigh the potential risks, giving European nations the green light to use the jab.
Responding to the EMA’s updates on Friday, J&J said that it would update its product information accordingly, while noting that the chances of such conditions are very low.
Latest posts by Niamh Harris (see all)
- The Unvaccinated Will Have To Suffer The “Consequences” Of Their Choices Says Justin Trudeau - June 26, 2022
- Biden’s Assistant Health Secretary: Sex Reassignment Surgery For Kids is “Lifesaving,Medically Necessary” - June 26, 2022
- Fauci Says His Own Experience With ‘Covid’ Shows Why It’s Important To Get Vaccinated - June 25, 2022